Answer
May 20, 2025 - 12:37 PM
Rinvoq (upadacitinib) is a medication used to treat certain inflammatory conditions, and like many medications, it carries potential risks. It has been associated with an increased risk of serious infections, blood clots, and certain cancers, which are highlighted in its boxed warning. Patients should discuss their individual risk factors with their healthcare provider to determine if Rinvoq is appropriate for them.
